HER-Targeted Tyrosine-Kinase Inhibitors

Publisher： Karger

E-ISSN： 1423-0232|63|1|6-16

ISSN： 0030-2414

Source： Oncology, Vol.63, Iss.1, 2002-11, pp. : 6-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Heart Failure as First Sign of Development of Cardiac Metastases in a Patient with Diagnosis of Papillary Thyroid Carcinoma on Treatment with Tyrosine-Kinase Inhibitors: Differential Diagnoses and Clinical Management

By  

Case Reports in Oncology, Vol. 7, Iss. 2, 2014-08 ,pp. : 591-599

Karger

Access to resources Recommend Favorite

Rapid and sensitive allele-specific (AS)-RT-PCR assay for detection of T315I mutation in chronic myeloid leukemia patients treated with tyrosine-kinase inhibitors

By Manrique Arechavaleta Gonzalo   Scholl Vanesa   Pérez Verónica   Bittencourt Roberta   Moellmann Arthur   Hassan Rocio   Seuánez Héctor   Dobbin Jane   Martinez Lem   Renault Ilana   Uriarte Rosario  

Clinical and Experimental Medicine, Vol. 11, Iss. 1, 2011-03 ,pp. : 55-59

Springer Publishing Company

Access to resources Recommend Favorite

Playing Russian Roulette With Tyrosine Kinase Inhibitors

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 93, Iss. 3, 2013-03 ,pp. : 242-244

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tyrosine Kinase Inhibitors Enhance Ciprofloxacin-Induced Phototoxicity by Inhibiting ABCG2

By  

Oncology, Vol. 87, Iss. 6, 2014-09 ,pp. : 364-370

Karger

Access to resources Recommend Favorite

Integrating Clinical Pharmacology Concepts in Individualized Therapy With Tyrosine Kinase Inhibitors

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 93, Iss. 3, 2013-03 ,pp. : 215-219

John Wiley & Sons Inc

Access to resources Recommend Favorite